◆英語タイトル：OncoMed Pharmaceuticals Inc (OMED) - Financial and Strategic SWOT Analysis Review
◆レポート形式：英語 / PDF
OncoMed Pharmaceuticals Inc (OncoMed) is a clinical-stage biopharmaceutical company focused on discovery and development of novel immuno-oncology (IO) therapeutics for the treatment of cancers. Its pipeline product candidates include navicixizumab, rosmantuzumab, Gitrl-FC Trimer, and anti-TIGIT. OncoMed’s research platform enables to build a portfolio of active therapeutic compounds that target biologic pathways critical for the growth, resistance, recurrence, and metastasis of cancer. The company’s expertise spans across cancer research, drug discovery, clinical development, regulatory affairs, translational medicine and commercial development. The company has strategic alliances with Celgene Corporation, Bayer Pharma AG and GlaxoSmithKline for the advancement of its clinical-stage candidates. OncoMed is headquartered in Redwood, California, the US.
OncoMed Pharmaceuticals Inc Key Recent Developments
Nov 09,2018: OncoMed Announces Early Clinical Data for anti-TIGIT Antibody
Nov 01,2018: Oncomed announces third quarter 2018 financial results and operational highlights
Oct 20,2018: OncoMed Announces Interim Phase 1b Results for Navicixizumab and Paclitaxel Combination Therapy in Platinum-resistant Ovarian Cancer
Sep 20,2018: OncoMed Provides Update on Navicixizumab Partnership[Newswire : Healthcare - GNW RSS]
Aug 02,2018: OncoMed announces second quarter 2018 financial results and operational highlights
This comprehensive SWOT profile of OncoMed Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OncoMed Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
OncoMed Pharmaceuticals Inc – Key Information
OncoMed Pharmaceuticals Inc – Overview
OncoMed Pharmaceuticals Inc – Key Employees
OncoMed Pharmaceuticals Inc – Key Employee Biographies
OncoMed Pharmaceuticals Inc – Key Operational Heads
OncoMed Pharmaceuticals Inc – Major Products and Services
OncoMed Pharmaceuticals Inc – History
OncoMed Pharmaceuticals Inc – Company Statement
OncoMed Pharmaceuticals Inc – Locations And Subsidiaries
OncoMed Pharmaceuticals Inc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
OncoMed Pharmaceuticals Inc – Business Description
OncoMed Pharmaceuticals Inc – Corporate Strategy
OncoMed Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
OncoMed Pharmaceuticals Inc – Strengths
OncoMed Pharmaceuticals Inc – Weaknesses
OncoMed Pharmaceuticals Inc – Opportunities
OncoMed Pharmaceuticals Inc – Threats
OncoMed Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Performance Charts
OncoMed Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
OncoMed Pharmaceuticals Inc, Key Information
OncoMed Pharmaceuticals Inc, Key Ratios
OncoMed Pharmaceuticals Inc, Share Data
OncoMed Pharmaceuticals Inc, Major Products and Services
OncoMed Pharmaceuticals Inc, History
OncoMed Pharmaceuticals Inc, Key Employees
OncoMed Pharmaceuticals Inc, Key Employee Biographies
OncoMed Pharmaceuticals Inc, Key Operational Heads
OncoMed Pharmaceuticals Inc, Other Locations
OncoMed Pharmaceuticals Inc, Subsidiaries
OncoMed Pharmaceuticals Inc, Key Manufacturing facilities
OncoMed Pharmaceuticals Inc, Key Competitors
OncoMed Pharmaceuticals Inc, SWOT Analysis
OncoMed Pharmaceuticals Inc, Ratios based on current share price
OncoMed Pharmaceuticals Inc, Annual Ratios
OncoMed Pharmaceuticals Inc, Interim Ratios
Capital Market Ratios
List of Figures
OncoMed Pharmaceuticals Inc, Performance Chart
OncoMed Pharmaceuticals Inc, Ratio Charts
OncoMed Pharmaceuticals Inc (OMED)：企業の財務・戦略的SWOT分析(OncoMed Pharmaceuticals Inc (OMED) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。